Loading provider…
Loading provider…
Hematology & Oncology Physician in Orlando, FL
NPI: 1255315933Primary Practice Location
ORLANDO HEALTH
92 W Miller St, Orlando, FL
Primary Employer
Orlando Health Medical Group Inc
orlandohealth.com
HQ Phone
Get MD Jose's Phone NumberMobile
Get MD Jose's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2001 - 2027
TX State Medical License
1999 - 2005

American Board of Internal Medicine
Hematology
University of Texas Health Science Center at Houston
Fellowship • Hematology and Medical Oncology
1998 - 2001
Washington University/B-JH/SLCH Consortium
Residency • Internal Medicine
1995 - 1998
University of Puerto Rico, Medical Sciences Campus
md.rcm.upr.edu
Medical School
Until 1995
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 149 | 209 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 118 | 194 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 34 | 94 |
| 4 | 99204New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
| 5 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 20 | 83 |
Inherited factor II deficiency with paradoxical hypercoagulability: a case report.
Authors: Mario Madruga, Ariel Perez Perez, Stephen Carlan, Kwabena Ayesu
Journal: Blood Coagul Fibrinolysis
Authors: Mario Madruga, Nawid Sarwari, Jacqueline Kropf, Sammy Moussly
Journal: J Hematol
Publication Date: 2019-09-30
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, DRUG: Prednisone, DRUG: Vincristine Sulfate, DRUG: Methotrexate, PROCEDURE: Computed Tomography, PROCEDURE: X-Ray Imaging, DRUG: Vincristine, DRUG: Dasatinib, BIOLOGICAL: Blinatumomab, DRUG: Mercaptopurine, PROCEDURE: Biopsy Procedure, PROCEDURE: Echocardiography Test, PROCEDURE: Bone Marrow Aspiration and Biopsy, PROCEDURE: Lumbar Puncture, DRUG: Methotrexate Sodium
Lead Sponsor: Molecular Templates, Inc.
Intervention / Treatment: DRUG: MT-3724 Phase 1, DRUG: MT-3724 Phase 2
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, OTHER: Questionnaire Administration, BIOLOGICAL: Nivolumab, PROCEDURE: Positron Emission Tomography, PROCEDURE: Biospecimen Collection, BIOLOGICAL: Pegfilgrastim, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, DRUG: Dacarbazine, DRUG: Brentuximab Vedotin, PROCEDURE: Computed Tomography, BIOLOGICAL: Filgrastim, DRUG: Vinblastine Sulfate, DRUG: Doxorubicin Hydrochloride